INFLUENCE OF VDR (RS731236) AND NOS3 (RS1143634) GENE VARIANTS ON CARDIOMETABOLIC PROFILE INDICATORS IN NEWBORNS
Clinical medicine

INFLUENCE OF VDR (RS731236) AND NOS3 (RS1143634) GENE VARIANTS ON CARDIOMETABOLIC PROFILE INDICATORS IN NEWBORNS

Published 2026-02-04

Authors:

V.I. Pokhylko
Poltava State Medical University image/svg+xml
https://orcid.org/0000-0002-1848-0490
Y.I. Cherniavska
Poltava State Medical University image/svg+xml
https://orcid.org/0000-0002-4522-7538
O.V. Yakovenko
Poltava State Medical University image/svg+xml
https://orcid.org/0009-0001-1062-9035
A.V. Davydenko
Poltava State Medical University image/svg+xml
https://orcid.org/0000-0002-4042-644X
Z.I. Rossokha
Shupyk National Healthcare University of Ukraine image/svg+xml
https://orcid.org/0000-0002-4767-7364

Abstract:
The study of genetic factors that influence the development of hypoxic-ischemic lesions in newborns is a relevant area of modern neonatology. The study analyzed the associations between NOS3 and VDR gene polymorphisms and clinical and cardiohemodynamic indicators in newborns, taking into account the mother's condition. Multivariate regression analysis showed that the CC VDR genotype was associated with a decrease in blood pressure (β=−8.17; p=0.016). The most significant predictor of blood pressure was venous blood pH (OR=0.61, p=0.004). The TT genotype of the NOS3 gene was associated with a significant increase in the risk of hypotension in newborns with hypoxic-ischemic CNS injury (OR=11.7; p=0.043). The identified trends in changes in cardiac function and vascular tone suggest a possible role for genetic mechanisms in shaping individual responses to hypoxia. The results obtained expand understanding of the pathogenesis of neonatal disorders and can inform risk stratification and treatment personalization.
Keywords:
VDR NOS3 newborns cardiometabolic profile Hypoxic-ischemic central nervous system injury gene variants blood pressure
References:
  1. Abouzid M, Kruszyna M, Burchardt P, Kruszyna L, Główka FK, Karaźniewicz-Łada M. Vitamin D receptor gene polymorphism and vitamin D status in population of patients with cardiovascular disease – a preliminary study. Nutrients. 2021;13:3117. https://doi.org/10.3390/nu13093117.
  2. Berezenko VS, Mykhailiuk KhZ, Rossokha ZI, Kyriachenko SP. Correlation of polymorphous variants (ApaI, TaqI, BsmI) of the VDR receptor gene with the vitamin D level and liver fibrosis in children with autoimmune hepatitis. Zaporozhye Med J. 2019;21(4):458-465. doi:10.14739/2310-1210.2019.4.173196.
  3. Carbone F, Liberale L, Libby P, Montecucco F. Vitamin D in atherosclerosis and cardiovascular events. Eur Heart J. 2023;44(23):2078-2094. doi: 10.1093/eurheartj/ehad165.
  4. Chekalina NI. Resveratrol has a positive effect on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease. Wiad Lek. 2017;70(2):286-291.
  5. Creo AL, Tebben PJ, Fischer PR, Thacher TD, Pittock ST. Cardiac arrest in a vitamin D-deficient infant. Glob Pediatr Health. 2018;5:2333794X18765064. doi:10.1177/2333794X18765064.
  6. Cyr AR, Huckaby LV, Shiva SS, Zuckerbraun BS. Nitric oxide and endothelial dysfunction. Crit Care Clin. 2020;36(2):307–321. doi: 10.1016/j.ccc.2019.12.009.
  7. Galleze A, Djaballah-Ider FZ, Gouaref I, Atmani SM, Allal K, Touil-Boukoffa C, et al. Involvement of vitamin D receptor gene polymorphism in increased cardiovascular risk disease in the Algerian population. Int J Mol Sci. 2025;26(19):9627. doi:10.3390/ijms26199627.
  8. Muscogiuri G, Altieri B, Annweiler C, Balercia G, Pal HB, Boucher BJ, et al. Vitamin D and chronic diseases: the current state of the art. Arch Toxicol. 2017;91(1):97–107. doi: 10.1007/s00204-016-1804-x.
  9. Neyestani TR. Vitamin D receptor (VDR) gene polymorphisms modify the response to vitamin D supplementation: a systematic review and meta-analysis. Nutrients. 2022;14(3):559. doi:10.3390/nu14030559.
  10. Siyah Bilgin B, Gonulal D. Association between vitamin D level and community-acquired late-onset neonatal sepsis. Arch Argent Pediatr. 2020;118(4):265-272. doi: 10.5546/aap.2020.eng.265.
  11. Stuehr DJ, Haque MM. Nitric oxide synthase enzymology in the 20 years after the Nobel Prize. Br J Pharmacol. 2019;176(2):141–153. doi: 10.1111/bph.14533.
  12. Sun H, Long SR, Li X, Ge H, Liu X, Wang T, et al. Serum vitamin D deficiency and vitamin D receptor gene polymorphism are associated with increased risk of cardiovascular disease in a Chinese rural population. Nutr Res. 2019;61:13-21. doi:10.1016/j.nutres.2018.09.002.
  13. Tabaei S, Motallebnezhad M, Tabaee SS. Vitamin D receptor (VDR) gene polymorphisms and risk of coronary artery disease (CAD): systematic review and meta-analysis. Biochem Genet. 2021;59(4):813-836. doi:10.1007/s10528-021-10038-x.
  14. Tsuber V, Kadamov Y, Brautigam L, Berglund UW, Helleday T. Mutations in cancer cause gain of cysteine, histidine, and tryptophan at the expense of a net loss of arginine on the proteome level. Biomolecules. 2017;7(3):49. http://dx.doi.org/10.3390/biom7030049
  15. Yuan N, Zhao D, Xu X, Zhang X. Maternal prepregnancy overweight: associations with maternal and offspring weight 4–7 years postpartum.J Diabetes Res. 2026;2026:9989579. doi:10.1155/jdr/9989579.
Publication:
«World of Medicine and Biology» Vol. 22 No. 1 (2026) , с. 113-117
УДК 616-053.31:612.6.05:616.1:616-008.9-07